TNF and inflammatory bowel disease: Immunomodulators such as thiopurines (for example azathioprine (AZA) and 6-mercaptopurine) and methotrexate (MTX) or biological medications such as anti-TNF agents, are commonly used in children with IBD, but have been associated with concerns regarding cancer risk (19–35).